Treatment outcomes for metastatic castrate-resistant prostate cancer (mCRPC) patients (pts) following docetaxel (D) for hormone sensitive disease

被引：0
|
作者：
Schmidt, Andrew Lachlan
Anton, Angelyn
Wong, Shirley S.
Azad, Arun
Kwan, Edmond Michael
Spain, Lavinia Anne
Torres, Javier
Muthusamy, Arunbalaji
Parente, Phillip
Parnis, Francis
Goh, Jeffrey C.
Joshua, Anthony M.
Pook, David William
Gibbs, Peter
Tran, Ben
Weickhardt, Andrew James
机构：
[1] Dept Med Oncol, Brisbane, Qld, Australia
[2] Peter MacCallum Canc Ctr, Melbourne, Australia
[3] Western Hosp, Brunswick, ME, Australia
[4] Monash Hlth, Dept Med Oncol, Melbourne, Australia
[5] Monash Univ, Melbourne, Australia
[6] Goulburn Valley Hlth, Shepparton, Australia
[7] Austin Hlth, Melbourne, Vic, Australia
[8] Eastern Hlth, Melbourne, Vic, Australia
[9] Monash Univ, Eastern Hlth Clin Sch, Melbourne, Vic, Australia
[10] Adelaide Canc Ctr, Adelaide, SA, Australia
[11] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
[12] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[13] Monash Hlth, Dept Med Oncol, Melbourne, Vic, Australia
[14] Royal Melbourne Hosp, Melbourne, Vic, Australia
[15] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[16] Austin Hlth, Olivia Newton John Canc Wellness & Res Ctr, Melbourne, Vic, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
78
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Feasibility of continuing docetaxel-based therapy in patients with metastatic castrate-resistant prostate cancer (mCRPC) that experience hypersensitivity reactions (HSR)
    Couvillon, Anna
    Beatson, Melony A.
    Harold, Nancy
    Karzai, Fatima H.
    Madan, Ravi Amrit
    Gulley, James L.
    Dahut, William L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [42] Evolution of docetaxel-based therapy for metastatic castrate-resistant prostate cancer
    Cornford, Philip
    JOURNAL OF CLINICAL UROLOGY, 2010, 3 (06) : 225 - 230
  • [43] Association of chromosomal instability with poor prognosis in metastatic hormone sensitive and castrate-resistant prostate cancer
    Rebernick, Ryan J.
    Hammer, Liat
    McFarlane, Matthew
    Westbrook, Thomas
    Hazime, Munna
    Hammoud, Tanya
    Chiu, Pin-En
    Wu, Yi-Mi
    Robinson, Dan
    Spratt, Daniel Eidelberg
    Alva, Ajjai S.
    Jackson, William C.
    Reichert, Zachery R.
    Chinnaiyan, Arul
    Alumkal, Joshi J.
    Dess, Robert T.
    Cieslik, Marcin
    CANCER RESEARCH, 2023, 83 (07)
  • [44] Medication Payments by Insurers and Patients for the Treatment of Metastatic Castrate-Resistant Prostate Cancer
    Kaye, Deborah R.
    Lee, Hui-Jie
    Gordee, Alexander
    George, Daniel J.
    Ubel, Peter A.
    Scales, Charles D.
    Bundorf, M. Kate
    JCO ONCOLOGY PRACTICE, 2023, 19 (04) : 214 - +
  • [45] Olaparib in metastatic castrate-resistant prostate cancer
    不详
    BJU INTERNATIONAL, 2020, 126 (02) : 235 - 235
  • [46] The Effect of Prior Androgen Synthesis Inhibition on Outcomes of Subsequent Therapy With Docetaxel in Patients With Metastatic Castrate-Resistant Prostate Cancer
    Aggarwal, Rahul
    Halabi, Susan
    Kelly, William Kevin
    George, Daniel
    Mahoney, John F.
    Millard, Frederick
    Stadler, Walter M.
    Morris, Michael J.
    Kantoff, Philip
    Monk, J. Paul
    Carducci, Michael
    Small, Eric J.
    CANCER, 2013, 119 (20) : 3636 - 3643
  • [47] A phase I study of the multikinase inhibitor cabozantinib (C) plus docetaxel (D) and prednisone (P) in metastatic castrate-resistant prostate cancer (mCRPC)
    Karzai, Fatima H.
    Shah, Avani Atul
    Ojemuyiwa, Michelle A.
    Madan, Ravi Amrit
    Apolo, Andrea Borghese
    Dawson, Nancy Ann
    Arlen, Philip M.
    Theoret, Marc Robert
    Wright, John Joseph
    Chen, Clara
    Trepel, Jane B.
    Couvillon, Anna
    Chun, Guinevere
    Harold, Nancy
    Steinberg, Seth M.
    Price, Douglas K.
    Gulley, James L.
    Figg, William Douglas
    Dahut, William L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [48] Radioligand Therapy of Patients with Metastatic Castrate-Resistant Prostate Cancer
    Nemtsova, E. R.
    Pankratov, A. A.
    Morozova, N. B.
    Tischenko, V. K.
    Petriev, V. M.
    Krylov, V. V.
    Shegay, P. V.
    Ivanov, S. A.
    Kaprin, A. D.
    BIOLOGY BULLETIN, 2022, 49 (12) : 2285 - 2297
  • [49] Radioligand Therapy of Patients with Metastatic Castrate-Resistant Prostate Cancer
    E. R. Nemtsova
    A. A. Pankratov
    N. B. Morozova
    V. K. Tischenko
    V. M. Petriev
    V. V. Krylov
    P. V. Shegay
    S. A. Ivanov
    A. D. Kaprin
    Biology Bulletin, 2022, 49 : 2285 - 2297
  • [50] Treatment of Castrate-Resistant Prostate Cancer
    Logothetis, Christopher J.
    JOURNAL OF UROLOGY, 2013, 190 (02): : 439 - 440
12345